Meet our Director
Phone +44 (0) 7795 345 108
I’ve worked across the biopharma, clinical research, and wider life sciences for all of my adult life.
With over eleven years spent working on a global life sciences event portfolio for a major corporate, I climbed from selling delegate tickets, through managing sales teams, and on to leading commercial and strategic direction on a major clinical research event portfolio active across four continents. In the more immediate past, I’ve worked with investors and business owners in financing and M&A in the booming HealthTech space.
This experience has left me with a passion for this industry, and a deep interest and profound respect for the process of taking a drug or device “from bench to bedside”.
With over a decade spent living and breathing events, I’m about as aware as anyone can be of the value of face-to-face engagement in this sector and I’m convinced that there is no better location at which to forge connections than events and conferences.
The Covid-19 pandemic and the subsequent pivot to online events served to prove that physical events simply cannot be replicated through a webcam and, in a world that is increasingly digital and virtual, in-person conferences remain the best in class environment in which to engage with peers across the clinical research sector.
The Clinical Outsourcing Group (COG) events deliver engaged audiences of biopharma trial sponsors, attracted by well-researched and highly current agendas, presented by an exciting range of large and small biopharma, regulator, academic, and solution provider speakers. Across multiple agenda streams, over two days, and under one roof, each COG event brings together a diversified audience to cover everything from outsourcing and operations, to technology and innovation, to supply and logistics.
Alongside the content core of each event sits a commitment to audience ratio; balancing solution and service provider numbers to ensure results are delivered to both vendors and delegate attendees.
For all the technology developments of recent years, clinical research remains a “people business” and COG also represents an active online discussion community, providing a platform for engagement between events that is guided by our expert advisory panel as well as speakers from across the annual programme to tap into the industry’s greatest resource: its people.
We look forward to welcoming you to a COG Series event soon!
Pharmaceutical Business Conference Group